ARRB2 and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, ARRB2 is also implicated in the more aggressive blast-crisis phase (bcCML) of CML in which blast cells exhibit severely impaired differentiation and increased proliferation.